INTRODUCTION
Circulating human peripheral blood lymphocytes (PBL)l can be simulated in vitro by pokeweed mitogen (PWM) to undergo a complex series of cellular interactions which culminate in the increased production of immunoglobulin (Ig)G, M, and A (1) (2) (3) (4) (5) . This polyclonal stimulation of immunoglobulin involves bone marrow-derived (B) lymphocytes and several defined Received for publication 15 May 1978 and in revised form 27July 1978.
'Abbreviations used in this paper: BSA, bovine serum albumin; PBL, peripheral blood lymphocytes; PBS, phosphate-buffered saline; PWM, pokeweed mitogen.
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populations of thymus-derived (T) lymphocytes whose functions include enhancement, suppression (1) (2) (3) (4) (5) , and possible amplification (6) of the humoral immune functions. Identification of these T-cell subpopulations has resulted from differential sensitivity to irradiation and steroids (7) (8) (9) , from expression of membrane receptors (10, 11) , from exaggeration of certain functions during disease states (12) (13) (14) (15) , and from the fact the system is not constrained by allogeneic differences (2, 4, 5) .
In humans, circulating lymphocytes represent cellular subsets different from those found in other lymphoid tissues as evidenced by differential sensitivity to antigens and mitogens (16, 17) , and by the fact that circulating B lymphocytes poorly reexpress surface Ig after antibody stripping, whereas spleen and tonsil B lymphocytes regain surface Ig within 24 h (18) .
The in vitro homeostatic role for circulating lymphocytes, and in particular those lymphocytes responsive to PWM, has not yet been carefully defined. Our approach for investigating the role of human circulating lymphocytes responsive to PWM is the quantitation of the functional abilities of specific regulating and antibody-producing cell populations in vitro after a perturbation of the immune system by in vivo immunization.
In this report we demonstrate that after booster immunization of normal individuals with tetanus toxoid, there is a selective increase in the capacity of the blood lymphocytes from the immunized individuals to produce antitetanus toxoid antibody in vitro after PWM stimulation. myeloma proteins (19) Lymphocyte preparation and separation procedures. Human PBL suspensions were prepared by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, N. J.) differential sedimentation (20) ofheparinized blood obtained from normal volunteers between the ages of 25 and 35 yr. The blood was diluted with an equal volume of 0.15 M saline, and the suspension (30 ml) was layered over 15 ml of Ficoll-Hypaque (sp gr = 1.078-1.080). After centrifugation at room temperature (600 g, 35 min), the interface cells were removed and washed three times in minimal essential medium. T-and Blymphocyte fractions were separated by density sedimentation of spontaneous rosettes formed by T lymphocytes and sheep erythrocytes. The procedure was modified in that the sheep erythrocytes had been pretreated with 2-aminoethylisothiouronium bromide (21) .
Lymphocyte cultures. Either unfractionated, fractionated, or fractionated and recombined PBL were cultured in RPMI 1640 medium buffered with NaHCO2 and supplemented with 1-glutamine (10 mM), gentamicin (0.05 mg/ml), and 15% heat-inactivated fetal calf serum. All cultures were done in a final volume of 1.5 ml in 13 x 100-mm plastic tubes (Falcon 2027, Falcon Plastics, Div. BioQuest, Oxnard, Calif.) and contained PWM (Grand Island Biological Co., Grand Island, N. Y.) at a final dilution of 1/100 vol/vol. The tubes were incubated in a humidified atmosphere at 37°C with 5% CO2 for 1-9 days.
Radioimmunoassays. The quantitative radioimmunoassay for antitetanus toxoid antibody and total IgG synthesized in vitro were performed in microtiter plates (22) . For measurements of antitetanus toxoid antibody, the individual wells in microtiter plates were filled with tetanus toxoid at a concentration of 1 mg/ml and incubated overnight at room temperature. The following day, the tetanus toxoid was removed and each well individually washed with 1% bovine serum albumin (BSA) Fig. 1 demonstrates that increasing quantities of serum added in the first incubation resulted in a subsequent increased binding of the second antibody with saturation being reached between 40,000-50,000 cpm. From the specific activity of the radioiodinated second antibody (1,874 cpm/ng), this was found to correspond to 20-25 ng/well of rabbit anti-human IgG. The binding of rabbit antihuman IgG to the plate was linear below 10 ng, and all experimental antibody levels were subsequently determined with diluted samples resulting in the binding of <12 ng/well of rabbit anti-human IgG.
The binding of serum antitetanus toxoid antibodies to the plate could be reduced by the inclusion of soluble tetanus toxoid in the first incubation (Fig. 2) . Similarly, the binding of 1251-rabbit anti-human IgG to the antitetanus toxoid antibody on the plate could be inhibited by the addition of nonradiolabeled human IgG ( synthesis developed within 2 wk after booster immunization, reached maximum levels between 3-6 wk postimmunization, and declined by 9 wk (Fig. 4 A) . The synthesis of total IgG was constant for the duration of the experiment (Fig. 4 B) .
Absence, before boosting, ofcirculating helper T and B lymphocytes capable of reacting with PWM to synthesize an-titetanus toxoid antibody in vitro. Helper T-lymphocyte function, specific for the synthesis of antitetanus toxoid antibody, was evaluated in PBL from individuals before booster immunization by T-and Blymphocyte co-culture experiments. The T lymphocytes were irradiated (3,000 rad) before use to reduce suppressor T-lymphocyte influences.
After 8 days incubation in vitro with PWM, T-and Blymphocyte combinations from three individuals boosted 14 days before the experiment synthesized an average of 190 U of antitetanus toxoid antibody (Fig. 5) . The combination of B and T lymphocytes from nonboosted individuals consistently synthesized only background levels of antitetanus toxoid antibody. When T lym-iphocytes (1.6 x 106) from nonboosted individuals were co-cultured with B lymphocytes (0.4 x 106) from boosted individuals, an average of 52 U specific antibody were synthesized. The synthesis of total IgG was unimpaired.
The nonboosted individuals were then immunized and the helper function of the T lymphocyte was reassessed 14 antitetanus toxoid antibody when irradiated T lymphocytes from boosted individuals were added. Again In Vitro Antibody Synthesis after Immunization (24) ; (40) antitetanus ititetanus toxoid demonstrated that lymphocytes capable of binding th each point. radiolabeled tetanus toxoid circulated in the blood with a frequency of 8/5,000 total lymphocytes. This is ex of suppres-within the range of antigen-binding cells detected in axoid antibody the spleens of mice and guinea pigs after immuniza-50, suggesting tion with a variety of antigens (25, 26) . These cells ell suppression most likely represent B lymphocytes because of their tetanus toxoid multiplicity of high affinity receptors (27) . Additional evidence for the existence of tetanus toxoid B lymphoof antitetanus cytes in the circulation of primed (not boosted) indio evaluated at viduals has come from the work of Geha et al. (28) who Fhis parameter demonstrated that in the presence of a tetanus toxoidy synthesized specific T-cell factor, B lymphocytes from nonboosted nce of 1.6 x 106 individuals produce antitetanus toxoid antibody in nd is shown in vitro. Our results, however, have shown that an antiin Fig. 6 . The tetanus toxoid antibody response cannot be initiated by ed at approxi-PWM in vitro before an in vivo booster immunization.
)roaching base-This would imply either a lack of, or insufficient ,ults were ob-numbers of, tetanus toxoid recognative B lymphocytes )btained that are reactive with PWM. The radioimmuno-I for autologous assay we employ is capable of detecting the specific decreased B-antitetanus toxoid antibody synthesized by the plasma sufficient num-cell progeny of one to three (depending on division both increased time) B lymphocytes over an 8-day incubation. Our culsed B-lympho-tures contain 4 x 105 B lymphocytes, and we should the decline in therefore be able to detect the synthesis of antitetanus oxoid antibody toxoid antibody in cultures of PBL where the frezation.
quency oftetanus toxoid-specific B cells would be -1/1 x 105. As tetanus toxoid-binding lymphocytes circulate with a frequency of -1/1,000 B cells, it would suggest -driven in vitro that the majority of these cells do not respond to PWM monstrated the in vitro before recent antigen exposure by booster imIly defined sub-munization.
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R. H. Stevens and A. Saxon --I ------------PWM stimulation of immunoglobulin synthesis is modulated by T lymphocytes, and it is possible that booster immunization is required to generate sufficient numbers ofT lymphocytes which may promote the synthesis of antitetanus toxoid antibodies in vitro. However, the existence of circulating antigen-specific T lymphocytes before booster immunization can be inferred from the studies of McMichael et al. (29) and Sasazuki et al. (30) who demonstrated a significant in vitro proliferative response of human PBL from nonboosted individuals when cultured with tetanus toxoid. This proliferative response has been shown by Chess et al. (31) to be mainly a T-cell function. Additionally, Geha et al. (28) have generated a factor from T lymphocytes that can induce the synthesis of IgG antitetanus toxoid antibody when added to primed B lymphocytes in vitro. This factor is generated in vitro by stimulating T lymphocytes with tetanus toxoid. Thus, although tetanus toxoid-binding B lymphocytes, and at least some tetanus toxoid-reactive T lymphocytes, may be present in the circulation of nonboosted individuals, PWM does not elicit an in vitro antitetanus toxoid antibody response before booster immunization.
In contrast to our findings, the production of antisheep erythrocyte antibodies (IgM) 
